Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation.

Benz, Alexander P; Hohnloser, Stefan H; Eikelboom, John W; Carnicelli, Anthony P; Giugliano, Robert P; Granger, Christopher B; Harrington, Josephine; Hijazi, Ziad; Morrow, David A; Patel, Manesh R; Seiffge, David J; Shoamanesh, Ashkan; Wallentin, Lars; Yi, Qilong; Connolly, Stuart J (2023). Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation. European Heart Journal, 44(20), pp. 1807-1814. Oxford University Press 10.1093/eurheartj/ehad200

Text ehad200.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (543kB)

AIMS

The prognosis of patients with atrial fibrillation (AF) and ischemic stroke while taking oral anticoagulation is poorly understood. This study aimed to characterize the outcomes of patients following a stroke event while on oral anticoagulation.

METHODS AND RESULTS

Individual participant data from five pivotal randomized trials of antithrombotic therapy in AF were used to assess the outcomes of patients with a post-randomization ischemic stroke while on study medication (warfarin, standard-, or lower-dose direct oral anticoagulant regimen) during trial follow-up. The primary outcome was recurrent ischemic stroke after the first post-randomization ischemic stroke. The primary analysis included 1163 patients with a first post-randomization ischemic stroke while on study medication (median age 73 years, 39.3% female, 35.4% history of stroke before trial enrollment). During a median continued follow-up of 337 days, 74 patients had a recurrent ischemic stroke [cumulative incidence at 1 year: 7.0%, 95% confidence interval (CI) 5.2%-8.7%]. The cumulative incidence of mortality at 3 months after stroke was 12.4% (95% CI 10.5%-14.4%). Consistent results for the incidence of recurrent ischemic stroke at 1 year were obtained in an analysis accounting for the competing risk of death (6.2%, 95% CI 4.8%-7.9%) and in a landmark analysis excluding the first 2 weeks after the index stroke and only including patients without permanent study drug discontinuation since then (6.8%, 95% CI 4.6%-8.9%).

CONCLUSION

Patients with AF and ischemic stroke while on oral anticoagulation are at increased risk of recurrent ischemic stroke and death. These patients currently have an unmet medical need.

Interest & Impact

Downloads

0 since deposited on 12 Apr 2023
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item